← Evidence map

ArticleTrials2025

Metformin Impact on Maternal and Infant Cardiometabolic Health (MIMICH), an open-label randomised controlled trial, and Metformin Impact on Maternal and Cardiometabolic Health After Pregnancy (MIMICH II).

Anya Amica-Carpenter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Metformin Impact on Maternal and Infant Cardiometabolic Health (MIMICH), an open-label randomised controlled trial, and Metformin Impact on Maternal and Cardiometabolic Health After Pregnancy (MIMICH II). | Socratic